Due to its antioxidant properties, it effectively mitigates oxidative stress and promotes muscle regeneration through enhanced myofibrillar proliferation, hence decreasing muscle loss in an animal model of induced muscular atrophy (545)
If youre getting this medication from someone or some place thats not your actual doctor, this can be detrimental to your health, should you run into issues
Your provider can assess whether continuation, dose adjustment, or temporary pause of GLP-1 therapy is appropriate based on clinical context
At the highest dose, roughly 10.5% average body-weight reduction at 26 weeks, about 11.8% at 36 weeks, vs ~0.30.6% on placebo
Here is an official image and detailed information about Jascayd (nerandomilast), the recently approved drug for idiopathic pulmonary fibrosis (IPF): FDA Approval News: FDA Approves Jascayd Manufacturer Site: Jascayd by Boehringer Ingelheim #Pharmacy #DrugUpdate #IdiopathicPulmonaryFibrosis #FDAApproval #Jascayd #LungHealth #PharmaceuticalSciences #HealthcareInnovation To view or add a comment, sign in Last week I covered Lillys oral GLP-1
